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INTRODUCTION 
Colorectal cancer ranks third in male and the second in female 
worldwide (1).  Colorectal cancer varies 10 times in both sexes worldwide, 
Incidence are high in south Asian, South African countries (1). 
In Asia, colorectal cancer incidence varies widely, low when 
compared with developed countries to southern countries, and rapidly 
raised in economically developed (1, 2). 
According to Indian cancer registry age adjusted incidence in India 
are very minimal when compared with the world registry (2). Lifetime risk 
of dying from CRC is 2.5%. If diagnosed early 90% survival, localised 
cancer up to 40% (3).  
Sudden change in diet and physical activity causes rapid increase in 
colorectal cancer in economically transforming countries (4-9). 
Trend of colorectal cancer in India is rising (5), this trend is also 
seen in migrating population and also due to change in diet, life style and 
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physical activity (6-8). Incidence in India 4.3 (male), 3.4 (female) per lack, 
this is a population based study. 
Fecal occult blood, flexible sigmoidoscopy and colonoscopy are 
used as screening procedure in high incidence areas to  
reduce mortality (9). 
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REVIEW OF LITERATURE 
EPIDEMIOLOGY 
Higher rate of CRC is seen in developed countries with variable 
frequency in different population, less in women than men, because 
variation in environmental factors, diet, migrating from low risk to high 
risk area. 
Environment has major role in the aetiology of colorectal cancer as 
evidenced by inter regional variation in incidence, strong link exists 
between diet, physical activity and colorectal cancer (3). 
ETIOLOGY 
CAUSAL AND PROTECTIVE FACTORS IN COLORECTAL 
CANCER 
PROTECTIVE FACTORS         
• Non steroidal anti inflammatory drugs 
• HRT  
• Weight reduction 
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• Increased Physical activity  
• High Carotene  
• Vitamin  C  & D    
CASUAL FACTORS  
• Cigrate smoking   
• Diabetes mellitus  
• High fat & low fiber  
• Red meat consumption           
• Environmental carcinogen & mutagens  
• Heterocyclic amines   
• Low dietary selenium        
A prospective study including women of 34 to 59 yrs taking 
increased red meat, increased fat, and low fiber showed increased rate of 
colon cancer. This difference was mainly due to variable fat  
composition (3).  
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Rodents when fed on polyunsaturated and saturated fats, followed 
experimental injection of DMH will develop more of colonic 
adenocarcinomas induced by carcinogen than rodents fed on low fat diet. 
Britan study in BMJ published that large bowel cancer is 
frequently associated with high carbohydrate and low fiber, and also 
insisted on the priority of vegetable fibers in the protection of colon 
cancer in the long way (13-16). 
Urban residents have increased incidence than rural peoples (17). 
This is due to increased “Westernizations”. 
Dr. Malhotra’s paper showed that people on high fiber and fruits 
had no reduction in cancer incidence. 
One of British study says that increased case of cancer in 
vegetarians than with non vegetarians. 
Population based study comparing smokers and non smokers on 
vegetarian diet followed for many years have shown inverse association 
between diet and colon cancer. 
Large population based study for many years on persons with 
vegetarian diet showed low incidence of distal colon cancer (18-23).       
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Various RCT showed that people on high fruit and vegetables 
(cruciferous) found that reduce cancer risk by 25% to 40%.           
Population based trial on the effect of polyp recurrence by dietary 
intervention had no impact on the site, size, number and advanced 
adenomas.  
Interventional trial showed that antioxidants reduce cancer risk and 
adenoma recurrence (27-28). 
Increased fat in the food leads to more fatty acids, which in turn 
produces sterols acted by bacteria in colon to produce toxic substances 
like secondary bile acids and cholesterol metabolic products. 
This activates protein kinase c activated AP-1. This converts 
arachidonic acid to prostaglandin leads to cell proliferation.  
COX-2 inhibitors and NSAIDS low prostaglandin synthesis which 
in turn reduce colon cancer. 
Adenomas and cancer has positive association with cholesterol and 
lipoprotein and inverse with obesity and activity population based study. 
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FIBER 
Plant fiber is a mix of carbohydrates and noncarbohydrates have 
low causal factor of colorectal neoplasia (29, 30). Observational studies also 
support this.  
Mode of action:  
Fermentation of fiber by colonic bacteria, which reduces ph that 
inhibits carcinogenesis      
Bacterial metabolic enzymes are reduced  
Colonic transit is increased     
Bulk of stool is increased 
CALCIUM 
Calcium protects against colon cancer (31) a comparative study                     
calcium supplements reduces adenoma by 15%. 
FOLATE:                  
Folate deficiency causes more adenoma, supplements reduces 
adenoma. 
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Lifestyle 
Body Mass and physical activity 
Western life style, obesity, hormonal factors, insulin resistance all 
have increased incidence according to a population based study. 
Smoking 
Early studies have shown that carcinogenic by products are 
responsible.  
PATHOPHYSIOLOGY AND MOLECULAR GENETICS 
Precursor Lesions – Polyps 1) hyperplastic 2) adenomas    
Adenomas are classified into                
Tubular     
Villous     
Tubulovillous       
Carcinoma is more common in villous adenoma.        
Less association with colon cancer and hyperplastic polyp (9) . 
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Malignant hyperplastic polyps are as follows, site, size, number,  
Histo pathological finding and family history.  Sessile serrated 
adenoma is linked with colon cancer. A serrated adenoma arises from 
abnormal  crypt epithelium proliferation and has nuclear atypia  (31 33). 
BRAF genetic mutations, DNA methylation associated with 
serrated adenoma (34). High microsatellite instability is sporadic colon 
cancer (35). 
Serrated adenoma seen in areas of severe dysplasia, and share a 
common pathway in MSI-H pathway. 
Syndromic Colon Cancer 
Mendelian autosomal dominant inheritance on chrosome 5 q (36-39). 
Numerous adenomatous polyps develope in the colon after puberty and 
develop colon cancer (7).  
Veale (40) single dominant mutation in FAP 
Herrera (41) deletion in chromosome 5 with APC mutation 
Bodmer (42) Chromosome 5 has APC mutation 
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Kinzler (43) positional cloning identified the APC gene on 
chromosome 5  
HNPCC starts in the middle age, right side with few polyps.   
Peltomaki (44) HNPCC have MSI. 
Fishel (45) first human mismatch repair gene hMSH2 (hMLH2) 
Bronner (46) and Papadopoulos (47) second mismatch repair gene. 
Kolodner (48) have hMSH2 mutations. 
Sporadic Cancer 
Colon cancer follows adenoma carcinoma sequence, mismatch 
repair genes account for 15% in sporadic colon cancers (49), due to DNA 
hypermethylation. 
Majority of APC mutation in sporadic colon cancers (49), identified 
to arise from abrent crypt foci of the colonocytes whish is the earliest 
manifestation (50).   
75% will have p53 mutation in high grade dysplasia. 
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HISTOPATHOLOGY OF COLON CANCER 
Histology 
Colon cancers are classified as poor, moderate and well 
differeanted 
Gross Pathology 
Colon cancer can present as polyp that is with stock or without, 
proliferative growth, or constriction .   1% of diminutive polyps contain 
cancer (51).  Metastasis will be earlier in sessile than in pedunculated 
polyp, because it is very close to lymphatic drainage (52). Similarly flat 
lesions are grow fast to other areas than the stalk less polyp, because of 
cellular growth is not into the lumen. 
Left sided lesion are diagnosed earlier than right so less incidence 
of left colonic lesion. 
Staging of colon cancer 
Colon cancer spreads by   
Lymphatic drainage           
Vascular supply   
And local invasion 
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Dukes’ classification 
Stage A   sub mucosa not involved 
Stage B1   both sub mucosa and muscularis propria 
Stage B2    muscularis propria into the serosa 
Stage C   to regional lymph node 
Stage D    distant organ involvement 
TNM - classification  
Primary tumor (T) 
Local lymph node metastases (N) 
Distant metastases (M) , stage I to IV. 
STAGE 
I - Dukes’ A or B1 lesions 
II - Dukes’ B2 lesion 
III - Dukes’ C lesion 
IV corresponds to Dukes’ D lesion - 20% (60). 
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CLINICAL PRESENTATION 
Symptoms 
• Pain Abdominal    
• Altered  bowel habits    
• Bleeding per rectum 
• Easy fatigability 
• Loss of weight  (52-54). 
Unusual Clinical Presentations 
Acute colonic obstruction 
• Proliferative luminal growth 
• Intermittent obstruction 
Ischemic colitis  
• Proximal dilatation by malignant obstruction  
• Infiltration of the  vessels by cancer cells 
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Perforation 
• Acute can cause acute generalized peritonitis  
• inflammatory mass or abscess  
• Local peritoneal signs 
Fistulas - adjacent organs (bladder or small bowel) 
          Rectal bleeding 
Lab investigation  
Complete blood count  
Hemoglobin – anaemia (10)   
Blood sugar 
Serum electrolytes - abnormal in patients with diarrhoea (55)  
Hypoalbuminia (56)    
Raised sap due to liver secondary (57)  
CEA not useful in screening (58), preoperative high levels indicates 
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Poor prognosis (59), post operative increased level indicates 
incomplete resection or recurrence (60-61). 
Screening and diagnosis 
Air-contrast barium enema  
Proctosigmoidoscopy  
Flexible sigmoidoscopy   
CT colonography (“virtual colonoscopy”)   
PRINCIPLES OF SCREENING 
Secondary prevention is to identify existing preneoplastic and early 
neoplastic lesions and to treat them thoroughly and expeditiously 
Screening is done if the disease 
Is a community problem 
Effective treatment is available if the disease is found 
Sensitivity and specificity are more  
Acceptable by patients and physicians, 
Low cost     
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Recommendations for screening the population without risk factors 
Age 50 yrs  
  No other risk factors 
USPSTF GUIDELINES           
1) High sensitivity FOBT (guaiac-based or immunochemical) done 
every  
2) Flexible sigmoidoscopy every 3 yrs 
3) Colonoscopy every 10 yrs    
ACS, MSTF, ACS guidelines 
Every 10 years colonoscopy 
Every 5 years sigmoidoscopy 
Screening is for early detection and non-invasive tests to identify 
early Cancer reduced potential to prevent cancer because not able to 
detect Precancerous lesions and lesions that do not bleed. If anyone is 
Abnormal, colonoscopy.  
FOBT every year 
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 FIT every year 
 Fecal DNA as essential  
ACG guidelines  
By the age of 50 yrs                  
By 45 yrs in Africans 
Every 10 yrs colonoscopy   
Every 5 yrs sigmoidoscopy alternate method                   
Detected by, every year preferred fecal immunochemical tests  
The results of FOBTs 
Relays on the amount of blood loss 
Hemoglobin degraded 
Presence of interfering substance 
At least 2 mL of blood required 
Location of the lesion 
Bleeding from the lesion           
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Economical value for FOBTS        
Fecal occult blood test   NIL       
An ideal screening test is simple, inexpensive, accurate in terms of 
being positive if disease is present (sensitivity) or negative if the disease 
is absent (specificity),relatively safe, and acceptable to the patient. 
Appropriate screening test should screen for disease that is an important 
community health problem. Colorectal cancer fulfils this prerequisite. 
The goal of screening is not only early detection also reduced 
mortality. The cancers detected by screening will have a better prognosis 
than those that arenot. Colorectal cancer screening, can detect cancer 
precursors, that is, adenomatous polyps, this reduces the incidence of the 
relevant cancer, as has been well demonstrated for colorectal cancer 
screening using the FOBT (3).   
SCREENING TECHNIQUES  
G FOBT - Slide Guaiac Tests 
It is a Qualitative chromogen tests producing oxidative conversion 
of a colourless substance to a colored one in the presence of the 
pseudoperoxidase activity of haemoglobin 
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At least 2 mL three consecutive (daily) stools are required, digitally 
evacuated stools are not recommended (3). 
Hem occult, Hem occult II, with guaiac-impregnated paper and 
developing solutions (hydrogen peroxide in denatured alcohol)  
Sensitivity & specificity depends upon the fecal hydration 
(increases sensitivity) not recommended for average screening 
population,  storage decreases sensitivity, and  VITAMIN C that can 
produce  alternate reaction of the indicator dye.                      
Easy available  
Cost effect  
Easy applicable  
Large group of population based studies say that the compliance in 
elderly patients was 50 to 70%. With gfobt positive rate of 5-6%, 
adenoma detection rate of 40%, carcinoma of 5-10 % (106) . 
Large studies in asymptomatic patient’s have1% to 2.6%in 
nonhydrated slides, colonic neoplasm of 20%, carcinomas 5.6% to 18% 
Rehydration of slides will increase in positivity and sensitivity but 
in a decrease in specificity and positive predictive value. 
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In a randomised control trial with a study population of 46000, age 
group of 50- 80 years, fobt positive rate of 2.4% and 18 yrs follow up 
showed 33% reduction mortality rate (62).  
Other  RCT with a study population of 152850 , age group of 50- 
74 years , fobt  positive rate of 2.1%  and 08 yrs follow up showed 15% 
reduction mortality rate (63).  
Goteborg , Fune and New York study with population of 28000, 
61933, 22000 age group of more than 40 yrs, with fobt positive rate of 
1.9% , 1%, 1.4% and reduction rate of 10% to 40% for follow up of 10 
years. 
Other tests 
Hemoccult-type slide tests. 
Fecal immunochemical tests   
Detects human globin not affected by diet or drugs.  
A FIT from brush-based sampling technique and an immunogold 
membrane that employs a dual-antibody system specific for human 
hemoglobin has undergone initial evaluation, with sensitivity and 
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specificity for detection of clinically significant neoplasia in studies of 
asymptomatic and symptomatic patients 
Among volunteers compliance for FOBT was 50% to 80% but 
lower rates 15% to 30% for community screening programs, also is 
extremely important in determining the cost effectiveness    
DNA from the stool 
Colonic epithelial cells found in the fecal matter has both normal 
and cancer DNA detected by PCR amplification assay. 
Multicentre study in patients with colonic cancer and normal 
mucosa showed mutations in APC, p53, K-ras, and BAT-26 with 91% - 
100% specificity of 100% for (64,65) other study with  genetic mutations in 
TP53, other above detected mutations in 36 (71%)  (66). 
Incorporation of additional molecular markers may further improve 
test Sensitivity and specificity.  
Virtual colonoscopy    
Patient is prepared as colonoscopy and given oral contrast then CT 
taken colonography. No need for sedation, no drug allergy, safe, cane 
image sabdominal and extra abdominal organs (67,68).                             
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Videocapsule endoscopy 
Safe and effective but contraindicated in obstruction. 
FOLLOW-UP           
With proper diet restriction and fobt positive, can repeat or go for 
diagnostic test. If second test is negative follow up test every 3-6 months. 
If fobt is negative no other test is needed. 
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AIM OF THE STUDY 
• Fecal occult blood testing (g FOBT) in asymptomatic elderly 
individuals for colorectal cancer screening. 
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MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
 
Place of study  : Department of Digestive Health and  
Diseases, Government Peripheral 
Hospital,  
Anna nagar,  
Chennai     
 
Type of study  : Prospective study  
 
Period of Study  : March 2012 – Jan 2013    
 
Ethical committee  : Approval obtained  
 
Consent   : Informed consent obtained from all  
participants                            
 
Selection of Patients : Elderly asymptomatic individuals 
 
Inclusion criteria           :  Age 60-85 years.  
Both sexes   
 
Exclusion Criteria  : Family history of colorectal cancer   
Chronic constipation    
Bleeding per rectum                                                          
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Study methodology : Study is a prospective study, and the  
study group patients attending DDHD 
OPD, Annanagar satisfying the inclusion 
and exclusion criteria during the study 
period March 2012 to JAN 2013.     
 
Patients who come under inclusion criteria are given the prepration  
about the test and samples taken after written consent.               
Patients with positive FOBT are subjected to colonoscopy .  
Biopsy if lesion present and correlated.      
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RESULT 
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RESULTS 
Total number of patients enrolled in the study was 325, both male 
and female in the age group of 60-85 yrs.     
In the above said population g FOBT positivity rate was 38 
(11.6%) in Non hydrated slide. 
SEX DISTRIBUTION 
TABLE: 1 
SEX NO % 
Male 211 65.8 
Female 111 34.1 
        
 More of male patients participated in our study.  Attitude towards 
the by both male and female were studied.   Both the sexes’ had better 
knowledge about bowel cancer but small group did not show any interest          
after through explanation. 
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AGE WISE DISTRIBUTION 
TABLE:2 
AGE NO % 
60-65 92 28.3 
66-70 96 29.5 
71-75 68 20.9 
76-80 44 13.5 
81-86 25 7.6 
 
Elderly age group were included in the study, in that most common 
age group was 66-70 yrs 
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SMOKING HABIT 
TABLE :4 
SEX NO % 
Male 11 28.1% 
 
Smoking of Cigrate and beedi were taken. Most people were in the 
habit of smoking of more than 20-25 yrs of beedi. Cigrate is cost effective 
so less had the habit of smoking this. 
 
211
11
Male
Smokers
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BASAL METABOLIC RATE 
TABLE : 5 
BMI/KG/M NO % 
18-25 18 47.3 
25-29.9 12 31.5 
>30 8 21 
 
1. 18 -25 is normal       
2. 25-29.9 over weight      
3. >30  obese 
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ANAEMIA 
TABLE : 6 
SEX NO 
Male 13 
Female 5 
 
Anaemia was noticed in 18 patients mostly in male that to in 
patients with pathology all patients with polyp and cancers lesion had 
anaemia.         
Female patients mainly had clinical anaemia 
 
Male, 13
Female, 5
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DISTRIBUTATION OF HEMOGLOBIN PERCENTAGE 
TABLE : 6 
Hb % NO % 
7-8 7 18.4 
8-10 11 28.9 
11-12 16 42.1 
>12 14 36.8 
 
All anaemic patients had pathology in the form of polyp or cancer. 
Mainly the right side lesion. This right side lesion present with occult 
blood loss. Anaemia was common with large polyp.                     
All the patients who had cancer had anaemia. 
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COLONOSCOPIC   FINDING 
TABLE:7 
Colon finding no % 
Ulcer 6 15.7 
Diverticulum 9 23.6 
Foreign body 1 2.6 
Worm infestation 5 13 
Fobt pos but normal 
colon 
2 5.2 
Polyp 11 28.9 
Cancer                               4                                    10.5 
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Ulcer was present in 6 persons , male 5 and female 1. 
 Tiny ulcer, erythematous < 1-2mm , which very superficial, biopsy 
showed non specific colitis.   
 Common in recto sigmoid region followed by rectal area, more 
ulcers seen in recto sigmoid region.  
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FOREIGN BODY      
One out of 38 only one (2.6%)  had foreign body that to a big 
stapler pin swallowed 5 days ago, but the patient was given purgation. No 
previous of constipation, or history suggestive of perforation and 
examination was normal.  Patient had no psychiatric problems.      
WORM INFESTATION          
Five persons (13%)  had worm infestation, in that four were male 
and one female. All belong to low socioeconomic group mostly male (4) 
out of five. All were alcoholic with poor oral hygiene. All those patients 
were given tablet Albendazole 400 mg strat. All other family members 
were also given. 
FOBT POSITIVE BUT COLONOSCOPY NORMAL                
 Patients had FOBT positive but colonoscopy normal. Two female 
patients had normal colonoscopy, but both had coronary heart diseases 
patients . and was on asprin.      
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POLYP 
TABLE: 8 
SEX NO % 
Male 8 21% 
Female 3 7.9% 
  
 Total 11 patients had polyp, 8 male, 3 female patients.  
SITE OF THE POLYP    
Caecal polyp 03                  
Ascending polyp 02                 
Sigmoid polyp 01  
Multiple polyps 06      
Single polyp 05        
Multiple polyps 06    
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TYPES OF POLYPS 
TABLE: 9 
Polyp types no % 
Diminutive polyp 05 13% 
Hyperplastic polyp 03 7.8% 
Adenomatous polyp 03 7.8% 
      
Diminutive polyps are multiple polyps they are seen in many areas 
of the colon.   Less than 5mm in size, biopsy taken which shows non 
specific changes.  Most of the polyps were removed while biopsy.       
Hyperplastic polyp were 3 in number, there is very minimal chance 
of malignancy. They were listed for follow up every year.    
Adenomatous polyps were 03 in number, tubular adenoma 01, and 
villous adenoma 02.    
Tubular adenoma 01, size 1-2 cm. 
 Polypectomy done. 
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 Patient is under follow up. 
Site of the polyp is mainly sigmoid colon.  
Villous adenoma 02 in number located in caecum .      
Polyp with stalk both more than 2 cm, polypectomy done    
Patient had post polypectomy bleeding, injection adrenalin 1 in 
10000 injected into the polyp stalk immediate rescue done.           
Patient developed postural hypotension, repeat colonoscopy done 
which showed bleeding and adherent clot in the stalk, hemoclip applied 
and bleeding stoped.  Histopatholical examination showed free margin. 
Patient is under surveillance.   
Malignancies were found in four patients, three were male and one 
was female.    
One case had 2-3 cm nodular raised lesion in the caecum , biopsy 
showed well differentiated adenocarcinoma . This patient had anaemia on 
clinical examination and the Hb was 8.5 mg/dl. Patient was 
asymptomatic. And   
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Dukes A classification. Patient was sent for surgery. Right 
hemicolecotomy done patient is under surveillance. His preoperative 
CEA level was within normal limits.               
Second case showed elevated, nodular mucosa in the ascending 
colon below the hepatic flexure. Histopathological examination revealed 
adenocarcinoma, moderately differentiated. Dukes a staging, patient was 
referred for surgery lost follow up.  
Third patient was obese patient from low socioeconomic class with 
no risk factors except for her age. On colonoscopy she was found to have 
3-5 cm of ulcer proliferative lesion in the caecum extending into 
ascending colon. Biopsy revealed well differentiated adenocarcinoma , 
stage a. Again going back to her examination she had pallor and her Hb 
was 8. She had grade 3 dyspnoea.                     
Fourth case was hepatic flexure growth, male patient he had only 
belching but he was anaemic with Hb of 9. The growth was like 
unhealthy mucosa. Biopsy showed adenocarcinoma of poor 
differentiation. Patient has under gone extended right hemicolecotomy.                            
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DISCUSSION  
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DISCUSSION 
Study population including both sexes of age group 60-85 yrs.   
Total numbers were 325 patients, in which 38 patients showed 
FOBT positivity (11.6%) in non hydrated slides.             
In our study we screened have for low risk patients in elderly group 
so we have selected this age group.     
AGE WISE DISTRIBUTION:        
In our study we have included elderly age group, in that most 
common age group affected was 65-75 yrs.    
A as per our Indian study from Kashmir  states that commonest age 
group affected was 60-75 yrs.           
And also from UK population based study states that the common 
age group was 60 yrs.   
According to world cancer registry the age group affected was 60-
85 yrs.  
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Considering the above studies from various regions, elderly ages 
were more commonly affected, which was consistent with our study. 
Our population common age group was 66-70 yrs. 
SEX DISTRIBUTION:           
Our population consisted of 211 male and 111 female.                                
Male patient had 8 polyps and 3 male patients had cancerous 
lesion.                  
Mostly they were diminutive polyps, hyperplastic and 
adenomatous polyp. Three patients had adenomatous polyp.                        
Various studies from India and other countries have stated that 
male to female were 2.3:1.  
The results our study says that male to female was 2:1  
Which is very much correlating with other studies.   
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FOBT Positive rate                
Our study had 38 (11.6%) positive for FOBT.          
Studies from various parts of the world have shown that positive 
rate for FOBT 2.6%   to 5%. In hydrated slides up to 8%. Rehydration 
can increase positivity and sensitivity but specivity will reduce   
Fobt positive patients when screened show 5-10 % incidence of 
cancer, 20 -30% incidence of adenoma.   
One year positive predictive value of fobt is 8%, 2-10% at 2 yrs, 
11% by 4 yrs. 
When compared with other studies our population had more fobt 
positive rate in non hydrated slides with proper diet advice, collection and 
technique. 
Male population with fobt positive is 23 (60.5)  
Female population 15(39.4).   
In our study non hydrated slide had 11.6% positive rate.  
  
 
46 
 
DIET  
Strict vegetarian diet seen in 13 patients and non vegetarian diet in 
25 patients.  
Several epidemiological studies, case control studies stated that 
high intake of fiber, more of fruits and vegetables will reduce the 
incidence of colon cancer (70,71).   
Several other prospective cohort studies correlated age and dietary 
fiber which did not show reduced incidence of colon cancer (72).                   
According to our study more than 80% were taking non vegetarian.            
Even in vegetarian taking population no body were in the regular 
habit of taking high fiber and vegetables in their diet.  
Population based studies revealed that meat eating had significant 
incidence of colon cancer.         
In our study we had both veg and non veg eating people, 
commonly non veg eating persons. Detailed diet history said that they 
were in the habit of taking more chicken than meat.  
As said by previous studies these patients did not take the 
significant meat (73, 74).  
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Many people in our study had combined intake of chicken, mutton, 
and fish. The cause could be the different in levels of fat content.  
EFFECT OF DIET, SMOKING, PHYSICAL ACTIVITY, AND 
BMI.  
Adapting western life style, eating habits is common in our study.             
Eating habits is more consisted with previous studies.   
Smoking is risk factor in the causation of cancer colon. Due to 
perfusion of  the toxic substances in to the colon leading to cellular 
proliferation. In this study all were chronic smokers that are more than 
10-20 yrs. Both 
Cigrate and beedi (75,76,77). 
Association of chronic smoking and ca colon (78,79,80 81 82).  
Study states that chronic smoking has increased incidence of 
adenoma and carcinoma by causing damage to DNA, stimulating liver 
enzymes, leading to proliferation. 
 Reduced physical activity and rectal prostaglandin are well 
correlated in colon cancer in aetiology.  
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Daily activity of at least half to one hour is essential (83,84). 
Protection against advanced adenoma (85). 
Adenoma is associated with increased waist hip ratio (86). 
Multiple cause in formation of adenoma are 
Secretion of bile is minim  
Increased bowel movement 
Hormonal changes 
Reduction in insulin like growth factor.  
Studies from Indian states showed that westernisation in more 
towards the aetiology of cancer colon (87-94).  
Obesity is one of important risk factor. In our study 21% were 
obese. One patient who had proliferative growth was in the obese 
category.   
Overweigh was 31.5% in paper who also had growth.    
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Population based study in Indian cities states that overeating, 
reduced physical activity, increased BMI will all lead to increased 
incidence of cancer colon (14-17).    
Obesity is associated with micronutrients deficiency such as 
calcium, Folate, and selenium (95-98).   
Study from abroad states that adenoma is increased with increase in 
weight gain (99,100).  
Abdominal obesity is more common (101-102).  
International research paper has coated that increased in male will 
increase cancer death (103-105).  
Attitudes of the population towards colon cancer screening  
More females were refusing for this investigation, because of stool 
collection and manipulation. But their knowledge about this disease was 
very less. After explaining about the disease magnitude and screening 
program we managed to get 325 cases.   
Males were able to understand the disease progression but they 
partly refused because of negative family history.     
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But we managed to cases for screening in the male side by 
regularly explaining them.   
Case control study from UK , revealed men attitude towards colon 
cancer screening (5-9).  
This was very much consistent with our study.  
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Colonoscopy finding in all these patients are as follows  
Fobt positive but normal colon, these people had CAD and were on 
anti platelet drugs.    
Incidence of polyp in our study was 28.9%. no malignancy found 
in hpe examination.                   
American study revealed that post-mortem finding of polyp were 
50%  
Colonoscopy finding were only 40%.  
Increasing age has same effect on adenoma incidence (6, 7).      
Site predilection towards distal colon, if dia less than 5mm seen 
thought the colon (8, 21, 22).     
In this paper 50 were diminutive polyps, and hyper plastic. Only 
three were tubular and villous adenoma.  
We had four malignancies in our study, all were adenocarcinoma, 
and 3 patients were in stage a. One had large growth but stage a diseases. 
All patients underwent surgery and every other patient is at our follow up.             
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Comparing with all other various studies, the results of our study is 
compatible with the age group of study population 60-85 yrs.  
Male gender were more commonly involved, and also participated 
in the study.    
Sex incidence was 2:1 it is also comparable with other studies.     
FOBT positive results were increased; this was achieved with 
adequate preparation of the patient and technique.  
Because ease of administration, cost effectiveness, non invasive 
nature we were able to collect this sample.    
And more over this test has all the qualities of screening 
requirement’s. 
More over this colorectal cancer also a diseases that needs 
screening.  
According to the screening principle, ethics, and results we were 
able to diagnose early colon cancer in four patients, and also to reduce 
cancer morbidity and mortality.  
All the risk factors and aetiological factors were comparable with 
the previous studies.                                 
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CONCLUSIONS 
• Screening in asymptomatic elderly people with FOBT has resulted 
in detection of unsuspected malignancy, in early stage. 
• Reduced malignancy related morbidity and mortality . 
• Proof of the value of screening is available from our  analysis. 
• Our findings together with evidence from other trials suggest that 
consideration should be given   FOBT screening to reduce CRC 
mortality in the general population. 
• FOBT can be still recommended for colorectal cancer screening in 
a population based study. 
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PROFOMA 
NAME 
AGE 
SEX 
IP NO 
SOCIO ECONOMIC STATUS 
ADDRESS 
CHIEF COMPLAINTS 
           Abdominal pain 
           Abdominal distension 
           Loss of appetite 
           Loss of weight 
           Awareness of lump in abdomen 
           Altered bowel habits   
           Bleeding per rectum / Melina         
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DRUG HISTORY 
GENERAL EXAMINATION                        
Anemia                            
Lymphadenopathy               
VITALS:     PR:      BP:        TEMP:         BMI: 
 
SYSTEM EXAMINATION: 
ABDOMEN: 
CARDIO VASCULAR: 
RESPIRATORY: 
CENTRAL NERVOUS SYSTEM: 
INVESTIGATIONS: 
HB %       
MOTION OCCULT BLOOB: 
COLONOSCOPY: 
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MASTER CHART 
Age Sex Diet Smoking BMI Anaemia Hb% Colon Finding
64 m nv s 3 a2 u 
69 f v 3 a a3 d 
70 m nv 2 a2 u 
71 m nv s 1 a3 d 
75 f v 3 a1 n 
68 m nv 1 a a4 wi 
66 m nv 2 a3 fb 
65 f nv 1 a a2 wi 
78 m nv 1 a3 p 
80 m nv s 2 a4 p 
87 f v 3 a a3 p 
71 m nv 1 a1 d 
70 m nv s 2 a a3 d 
72 f nv 1 a a3 c 
73 m nv 2 a2 p 
74 m nv 1 a4 d 
77 f v 3 a a2 p 
60 m nv 1 a a4 d 
62 f nv 2 a a1 p 
65 m nv s 1 a3 u 
68 f nv 2 a a2 n 
74 f v 3 a3 p 
79 m nv s 1 a2 d 
81 f nv 2 a a1 p 
76 m nv s 1 a3 c 
70 m nv 1 a1 u 
69 f nv 2 a a3 p 
61 m nv s 1 a2 wi 
60 f v 1 a a3 d 
62 m nv 2 a1 p 
66 m nv s 1 a2 p 
73 m nv 1 a3 u 
72 f v 3 a a3 wi 
70 m nv s 1 a a2 c 
80 m nv 2 a3 d 
85 f v 1 a a1 c 
65 m nv s 3 a a3 u 
60 f v 2 a a2 wi 
 
 
